Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Preoperative staging of nodal status in gastric cancer.

Berlth F, Chon SH, Chevallay M, Jung MK, Mönig SP.

Transl Gastroenterol Hepatol. 2017 Feb 7;2:8. doi: 10.21037/tgh.2017.01.08. eCollection 2017. Review.

2.

Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients after Curative Resection.

Oh SJ, Suh BJ, Park JK, Oh SD, Yu HJ.

Case Rep Oncol. 2017 Jan 17;10(1):57-65. doi: 10.1159/000455189. eCollection 2017 Jan-Apr.

3.

Circulating tumour cells predict survival in gastric cancer patients: a meta-analysis.

Wang HY, Wei J, Zou ZY, Qian XP, Liu BR.

Contemp Oncol (Pozn). 2015;19(6):451-7. doi: 10.5114/wo.2015.56651. Epub 2016 Jan 13.

4.

The prognostic value of UHRF-1 and p53 in gastric cancer.

Babacan NA, Egilmez HR, Yücel B, Ilknur P, Seker MM, Kacan T, Bahceci A, Cihan S, Akinci B, Eriten B, Kilickap S.

Saudi J Gastroenterol. 2016 Jan-Feb;22(1):25-9. doi: 10.4103/1319-3767.173755.

5.

Study of regulatory promoter polymorphism (-248 G>A) of Bax gene in patients with gastric cancer in the northern provinces of Iran.

Mirmajidi SH, Najafi M, Mirmajidi ST, Nasri Nasrabadi N.

Gastroenterol Hepatol Bed Bench. 2016 Winter;9(1):36-44.

6.

Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study.

Marano L, Boccardi V, Braccio B, Esposito G, Grassia M, Petrillo M, Pezzella M, Porfidia R, Reda G, Romano A, Schettino M, Cosenza A, Izzo G, Di Martino N.

World J Surg Oncol. 2015 Jul 16;13:215. doi: 10.1186/s12957-015-0633-3.

7.

Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer.

Chu X, Yang ZF.

World J Surg Oncol. 2015 Jun 1;13:192. doi: 10.1186/s12957-015-0602-x.

8.

Aberrant CCR4 expression is involved in tumor invasion of lymph node-negative human gastric cancer.

Yang Y, Du L, Yang X, Qu A, Zhang X, Zhou C, Wang C.

PLoS One. 2015 Mar 19;10(3):e0120059. doi: 10.1371/journal.pone.0120059. eCollection 2015.

9.

Outcome analysis of laporoscopic D1 and D2 dissection in patients 70 years and older with gastric cancer.

Emir S, Sözen S, Bali I, Gürdal SÖ, Turan BC, Yıldırım O, Yetişyiğit T.

Int J Clin Exp Med. 2014 Oct 15;7(10):3501-11. eCollection 2014.

10.

Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis.

Zhang X, Zhang W, Feng LJ.

PLoS One. 2014 Nov 17;9(11):e111906. doi: 10.1371/journal.pone.0111906. eCollection 2014.

11.

Interleukin-23A is associated with tumor growth in Helicobacter-pylori-related human gastric cancer.

Liu C, Zhang Y, Zhan J, Zhao Y, Wan Q, Peng H, Zhu W.

Cancer Cell Int. 2014 Oct 16;14(1):104. doi: 10.1186/s12935-014-0104-x. eCollection 2014.

12.

Gastric cancer arising from the remnant stomach after distal gastrectomy: a review.

Takeno S, Hashimoto T, Maki K, Shibata R, Shiwaku H, Yamana I, Yamashita R, Yamashita Y.

World J Gastroenterol. 2014 Oct 14;20(38):13734-40. doi: 10.3748/wjg.v20.i38.13734. Review.

13.

Subtotal gastrectomy for gastric cancer.

Santoro R, Ettorre GM, Santoro E.

World J Gastroenterol. 2014 Oct 14;20(38):13667-80. doi: 10.3748/wjg.v20.i38.13667. Review.

14.

Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer.

Liu X, Long Z, Cai H, Huang H, Shi Y, Wang Y.

PLoS One. 2014 Aug 19;9(8):e105112. doi: 10.1371/journal.pone.0105112. eCollection 2014.

15.

Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years.

Rosa F, Alfieri S, Tortorelli AP, Fiorillo C, Costamagna G, Doglietto GB.

World J Surg Oncol. 2014 Jul 16;12:217. doi: 10.1186/1477-7819-12-217.

16.

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma.

Oblak I, Vidmar MS, Anderluh F, Velenik V, Jeromen A, Hadzic JB.

Radiol Oncol. 2014 Apr 25;48(2):189-96. doi: 10.2478/raon-2013-0065. eCollection 2014 Jun.

17.

Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.

Jiao XG, Deng JY, Zhang RP, Wu LL, Wang L, Liu HG, Hao XS, Liang H.

World J Gastroenterol. 2014 Apr 7;20(13):3640-8. doi: 10.3748/wjg.v20.i13.3640.

18.

STAT3 activation in tumor cell-free lymph nodes predicts a poor prognosis for gastric cancer.

Wu LJ, Li HX, Luo XT, Lu RZ, Ma YF, Wang R, Zhang J, Yang DQ, Yu H, Liu J.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):1140-6. eCollection 2014.

19.

Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis.

Zhang YW, Zhang YL, Pan H, Wei FX, Zhang YC, Shao Y, Han W, Liu HP, Wang ZY, Yang SH.

World J Gastroenterol. 2014 Jan 14;20(2):584-92. doi: 10.3748/wjg.v20.i2.584. Review.

20.

Comparison of five staging systems of lymph node metastasis in the gastric carcinoma.

Chehrei A, Amoueian S, Ansari J, Montazer M, Sanei MH.

J Res Med Sci. 2013 Oct;18(10):848-54.

Supplemental Content

Support Center